199 related articles for article (PubMed ID: 24895252)
1. MRI measures of corpus callosum iron and myelin in early Huntington's disease.
Di Paola M; Phillips OR; Sanchez-Castaneda C; Di Pardo A; Maglione V; Caltagirone C; Sabatini U; Squitieri F
Hum Brain Mapp; 2014 Jul; 35(7):3143-51. PubMed ID: 24895252
[TBL] [Abstract][Full Text] [Related]
2. Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study.
Johnson EB; Parker CS; Scahill RI; Gregory S; Papoutsi M; Zeun P; Osborne-Crowley K; Lowe J; Nair A; Estevez-Fraga C; Fayer K; Rees G; Zhang H; Tabrizi SJ;
EBioMedicine; 2021 Mar; 65():103266. PubMed ID: 33706250
[TBL] [Abstract][Full Text] [Related]
3. Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications.
Bartzokis G; Lu PH; Tishler TA; Fong SM; Oluwadara B; Finn JP; Huang D; Bordelon Y; Mintz J; Perlman S
Neurochem Res; 2007 Oct; 32(10):1655-64. PubMed ID: 17484051
[TBL] [Abstract][Full Text] [Related]
4. Microstructural brain abnormalities in Huntington's disease: A two-year follow-up.
Odish OF; Leemans A; Reijntjes RH; van den Bogaard SJ; Dumas EM; Wolterbeek R; Tax CM; Kuijf HJ; Vincken KL; van der Grond J; Roos RA
Hum Brain Mapp; 2015 Jun; 36(6):2061-74. PubMed ID: 25644819
[TBL] [Abstract][Full Text] [Related]
5. Myelin Breakdown in Human Huntington's Disease: Multi-Modal Evidence from Diffusion MRI and Quantitative Magnetization Transfer.
Bourbon-Teles J; Bells S; Jones DK; Coulthard E; Rosser A; Metzler-Baddeley C
Neuroscience; 2019 Apr; 403():79-92. PubMed ID: 28579146
[TBL] [Abstract][Full Text] [Related]
6. Elevated brain iron is independent from atrophy in Huntington's Disease.
Dumas EM; Versluis MJ; van den Bogaard SJ; van Osch MJ; Hart EP; van Roon-Mom WM; van Buchem MA; Webb AG; van der Grond J; Roos RA;
Neuroimage; 2012 Jul; 61(3):558-64. PubMed ID: 22480728
[TBL] [Abstract][Full Text] [Related]
7. Multimodal MRI analysis of the corpus callosum reveals white matter differences in presymptomatic and early Huntington's disease.
Di Paola M; Luders E; Cherubini A; Sanchez-Castaneda C; Thompson PM; Toga AW; Caltagirone C; Orobello S; Elifani F; Squitieri F; Sabatini U
Cereb Cortex; 2012 Dec; 22(12):2858-66. PubMed ID: 22223853
[TBL] [Abstract][Full Text] [Related]
8. Drumming Motor Sequence Training Induces Apparent Myelin Remodelling in Huntington's Disease: A Longitudinal Diffusion MRI and Quantitative Magnetization Transfer Study.
Casella C; Bourbon-Teles J; Bells S; Coulthard E; Parker GD; Rosser A; Jones DK; Metzler-Baddeley C
J Huntingtons Dis; 2020; 9(3):303-320. PubMed ID: 32894249
[TBL] [Abstract][Full Text] [Related]
9. Corpus callosal atrophy in premanifest and early Huntington's disease.
Crawford HE; Hobbs NZ; Keogh R; Langbehn DR; Frost C; Johnson H; Landwehrmeyer B; Reilmann R; Craufurd D; Stout JC; Durr A; Leavitt BR; Roos RA; Tabrizi SJ; Scahill RI;
J Huntingtons Dis; 2013; 2(4):517-26. PubMed ID: 25062736
[TBL] [Abstract][Full Text] [Related]
10. Multi-compartment analysis of the complex gradient-echo signal quantifies myelin breakdown in premanifest Huntington's disease.
Casella C; Kleban E; Rosser AE; Coulthard E; Rickards H; Fasano F; Metzler-Baddeley C; Jones DK
Neuroimage Clin; 2021; 30():102658. PubMed ID: 33865029
[TBL] [Abstract][Full Text] [Related]
11. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
Tabrizi SJ; Scahill RI; Durr A; Roos RA; Leavitt BR; Jones R; Landwehrmeyer GB; Fox NC; Johnson H; Hicks SL; Kennard C; Craufurd D; Frost C; Langbehn DR; Reilmann R; Stout JC;
Lancet Neurol; 2011 Jan; 10(1):31-42. PubMed ID: 21130037
[TBL] [Abstract][Full Text] [Related]
12. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.
Poudel GR; Stout JC; Domínguez D JF; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
Neurobiol Dis; 2015 Feb; 74():406-12. PubMed ID: 25497085
[TBL] [Abstract][Full Text] [Related]
14. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.
Rosas HD; Tuch DS; Hevelone ND; Zaleta AK; Vangel M; Hersch SM; Salat DH
Mov Disord; 2006 Sep; 21(9):1317-25. PubMed ID: 16755582
[TBL] [Abstract][Full Text] [Related]
15. Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection".
Rosas HD; Lee SY; Bender AC; Zaleta AK; Vangel M; Yu P; Fischl B; Pappu V; Onorato C; Cha JH; Salat DH; Hersch SM
Neuroimage; 2010 Feb; 49(4):2995-3004. PubMed ID: 19850138
[TBL] [Abstract][Full Text] [Related]
16. Striatal hypometabolism in premanifest and manifest Huntington's disease patients.
López-Mora DA; Camacho V; Pérez-Pérez J; Martínez-Horta S; Fernández A; Sampedro F; Montes A; Lozano-Martínez GA; Gómez-Anson B; Kulisevsky J; Carrió I
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2183-2189. PubMed ID: 27349245
[TBL] [Abstract][Full Text] [Related]
17. Altered brain iron content and deposition rate in Huntington's disease as indicated by quantitative susceptibility MRI.
Chen L; Hua J; Ross CA; Cai S; van Zijl PCM; Li X
J Neurosci Res; 2019 Apr; 97(4):467-479. PubMed ID: 30489648
[TBL] [Abstract][Full Text] [Related]
18. Diffusion imaging studies of Huntington's disease: A meta-analysis.
Liu W; Yang J; Burgunder J; Cheng B; Shang H
Parkinsonism Relat Disord; 2016 Nov; 32():94-101. PubMed ID: 27624391
[TBL] [Abstract][Full Text] [Related]
19. Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease.
Dumas EM; van den Bogaard SJ; Ruber ME; Reilman RR; Stout JC; Craufurd D; Hicks SL; Kennard C; Tabrizi SJ; van Buchem MA; van der Grond J; Roos RA
Hum Brain Mapp; 2012 Jan; 33(1):203-12. PubMed ID: 21264990
[TBL] [Abstract][Full Text] [Related]
20. Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.
Scahill RI; Zeun P; Osborne-Crowley K; Johnson EB; Gregory S; Parker C; Lowe J; Nair A; O'Callaghan C; Langley C; Papoutsi M; McColgan P; Estevez-Fraga C; Fayer K; Wellington H; Rodrigues FB; Byrne LM; Heselgrave A; Hyare H; Sampaio C; Zetterberg H; Zhang H; Wild EJ; Rees G; Robbins TW; Sahakian BJ; Langbehn D; Tabrizi SJ
Lancet Neurol; 2020 Jun; 19(6):502-512. PubMed ID: 32470422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
